IDO1 and depressive symptom measurement: Notably, increased activity of indoleamine 2, 3 dioxygenase 1 (IDO1), the first and rate-limiting enzyme of the KYN pathway [22] has been associated with diminished CNS 5-HT content, which is negatively correlated with the severity of depression symptoms [13, 23].